In The Cancer Genome Atlas (TCGA) and Genomic Spatial Event (GSE) databases, we found that a higher expression of AHR was correlated with a worse prognosis in patients with several cancer types, including breast cancer, lung cancer, glioma, and pancreatic adenocarcinoma (Figure 7A and Supplemental Figure 8A). This evidence concerns the gene AHR and central nervous system cancer.